欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号NL/H/3223/001
药品名称Solifenacin succinate Mylan 5 mg film-coated tablets
活性成分
    • solifenacin succinate 5.0 mg
剂型Film-coated tablet
上市许可持有人Mylan B.V. Dieselweg 25 3752 LB Bunschoten The Netherlands
参考成员国 - 产品名称Netherlands (NL)
Solifenacinesuccinaat Mylan 5 mg, filmomhulde tabletten
互认成员国 - 产品名称
    • Germany (DE)
      Solifenacinsuccinat Mylan 5 mg Filmtabletten
    • Denmark (DK)
      Solifenacin Mylan
    • Belgium (BE)
      Solifenacine Viatris 5 mg filmomhulde tabletten
    • Luxembourg (LU)
      Solifenacine, 5 mg, Comprimé pelliculé
    • Iceland (IS)
    • United Kingdom (Northern Ireland) (XI)
    • Ireland (IE)
    • France (FR)
    • Spain (ES)
    • Italy (IT)
    • Norway (NO)
      Solifenacin Mylan
    • Czechia (CZ)
      Solifenacin Mylan 5 mg
    • Slovakia (SK)
    • Austria (AT)
    • Finland (FI)
    • Croatia (HR)
    • Poland (PL)
      Solifenacin Mylan
    • Romania (RO)
许可日期2015/09/16
最近更新日期2023/11/30
药物ATC编码
    • G04BD08 solifenacin
申请类型
  • TypeLevel1:Abridged
  • TypeLevel2:Initial Application
  • TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase